Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Topics

Page Path

HOME
TOPICS
Topics

Review

Fecal microbiota transplantation in alcohol related liver diseases

Saggere Muralikrishna Shasthry

Clin Mol Hepatol. 2020;26(3):294-301. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0057

View: 7041 Download: 211 Web of Science: 20 Crossref: 23

Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis

Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada

Clin Mol Hepatol. 2020;26(3):280-293. Published online June 4, 2020

DOI: https://doi.org/10.3350/cmh.2020.0037

View: 7362 Download: 230 Web of Science: 11 Crossref: 12

Novel biomarkers for the management of chronic hepatitis B

Takako Inoue, Yasuhito Tanaka

Clin Mol Hepatol. 2020;26(3):261-279. Published online June 15, 2020

DOI: https://doi.org/10.3350/cmh.2020.0032

View: 14737 Download: 696 Web of Science: 71 Crossref: 73

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

Chung-Feng Huang, Ming-Lung Yu

Clin Mol Hepatol. 2020;26(3):251-260. Published online March 19, 2020

DOI: https://doi.org/10.3350/cmh.2020.0018

View: 14397 Download: 388 Web of Science: 38 Crossref: 41

Special Topic

Management of liver diseases during the pandemic of coronavirus disease-19

Ju-Yeon Cho, Soon Sun Kim, Young-Sun Lee, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim

Clin Mol Hepatol. 2020;26(3):243-250. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0111

View: 7055 Download: 231 Web of Science: 8 Crossref: 7

Letter to the Editor

Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease

Jung Hwan Yu

Clin Mol Hepatol. 2020;26(2):240-241. Published online March 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0048

View: 3919 Download: 45 Web of Science: 1 Crossref: 1

Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma

Hwi Young Kim, Jean-François Dufour

Clin Mol Hepatol. 2020;26(2):238-239. Published online March 18, 2020

DOI: https://doi.org/10.3350/cmh.2020.0051

View: 3889 Download: 61 Web of Science: 1 Crossref: 1

Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?

Hyuk Soo Eun

Clin Mol Hepatol. 2020;26(2):236-237. Published online April 7, 2020

DOI: https://doi.org/10.3350/cmh.2020.0040

View: 3595 Download: 45

A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B

Yang-Hyun Baek

Clin Mol Hepatol. 2020;26(2):233-235. Published online April 7, 2020

DOI: https://doi.org/10.3350/cmh.2020.0039

View: 4364 Download: 143

Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps

Rodrigo Cañada Trofo Surjan, Elizabeth Santana dos Santos, Sergio do Prado Silveira, Fabio Ferrari Makdissi, Marcel Autran Cesar Machado

Clin Mol Hepatol. 2020;26(2):231-232. Published online November 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.0084

View: 4053 Download: 85 Web of Science: 3 Crossref: 3

Multimodal sequential treatment for occluded TIPS: Case report and review of literature

Nicoletta De Matthaeis, Carmine Di Stasi, Fabrizio Pizzolante, Riccardo Manfredi, Gian Ludovico Rapaccini, Luca Miele

Clin Mol Hepatol. 2020;26(2):227-230. Published online November 18, 2019

DOI: https://doi.org/10.3350/cmh.2019.0056

View: 5778 Download: 155

Original Article

Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease

Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky

Clin Mol Hepatol. 2020;26(2):216-226. Published online December 5, 2019

DOI: https://doi.org/10.3350/cmh.2019.0074

View: 6579 Download: 140 Web of Science: 14 Crossref: 12

Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017

Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim

Clin Mol Hepatol. 2020;26(2):209-215. Published online November 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.0065

View: 33815 Download: 403 Web of Science: 76 Crossref: 79

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma

Rahul Kumar, Boon-Bee George Goh, Jia-Wen Kam, Pik-Eu Chang, Chee-Kiat Tan

Clin Mol Hepatol. 2020;26(2):196-208. Published online January 9, 2020

DOI: https://doi.org/10.3350/cmh.2019.0012

View: 8047 Download: 269 Web of Science: 14 Crossref: 14

The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?

Sujata Lall, Pragya Agarwala, Guresh Kumar, Manoj Kumar Sharma, Ekta Gupta

Clin Mol Hepatol. 2020;26(2):187-195. Published online April 7, 2020

DOI: https://doi.org/10.3350/cmh.2019.0060

View: 10465 Download: 336 Web of Science: 12 Crossref: 12

Editorial

Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?

Soung Won Jeong

Clin Mol Hepatol. 2020;26(2):185-186. Published online March 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0046

View: 4345 Download: 87 Web of Science: 1 Crossref: 1

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?

Ju Hyun Shim

Clin Mol Hepatol. 2020;26(2):183-184. Published online March 12, 2020

DOI: https://doi.org/10.3350/cmh.2020.0042

View: 4212 Download: 111 Web of Science: 6 Crossref: 6

Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?

Hyun Woong Lee

Clin Mol Hepatol. 2020;26(2):180-182. Published online April 7, 2020

DOI: https://doi.org/10.3350/cmh.2020.0045

View: 4051 Download: 105

Review

Switching to systemic therapy after locoregional treatment failure: Definition and best timing

Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato

Clin Mol Hepatol. 2020;26(2):155-162. Published online January 15, 2020

DOI: https://doi.org/10.3350/cmh.2019.0021n

View: 9783 Download: 408 Web of Science: 41 Crossref: 38

Drug induced liver injury: East versus West – a systematic review and meta-analysis

En Xian Sarah Low, Qishi Zheng, Edwin Chan, Seng Gee Lim

Clin Mol Hepatol. 2020;26(2):142-154. Published online December 10, 2019

DOI: https://doi.org/10.3350/cmh.2019.1003

View: 9114 Download: 531 Web of Science: 24 Crossref: 26

Application of transient elastography in nonalcoholic fatty liver disease

Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2020;26(2):128-141. Published online November 8, 2019

DOI: https://doi.org/10.3350/cmh.2019.0001n

View: 13927 Download: 561 Web of Science: 59 Crossref: 63

Guideline

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020

DOI: https://doi.org/10.3350/cmh.2019.0010n

View: 20887 Download: 1,334 Web of Science: 68 Crossref: 65

Review

Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source

Feng Chen, Hua Wang, Jia Xiao

Clin Mol Hepatol. 2020;26(2):163-179. Published online February 27, 2020

DOI: https://doi.org/10.3350/cmh.2019.0022n

View: 9545 Download: 263 Web of Science: 4 Crossref: 3

Letter to the Editor

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms

Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2020;26(1):78-82. Published online November 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0078

View: 5965 Download: 174 Web of Science: 4 Crossref: 4

Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma

Nimish Thakral, Douglas A. Simonetto

Clin Mol Hepatol. 2020;26(1):74-77. Published online August 16, 2019

DOI: https://doi.org/10.3350/cmh.2018.0042

View: 6520 Download: 136 Web of Science: 7 Crossref: 10

The management of polycystic liver disease by tolvaptan

Tsuneo Takenaka, Soichiro Miura, Masaki Kitajima

Clin Mol Hepatol. 2020;26(1):70-73. Published online June 13, 2019

DOI: https://doi.org/10.3350/cmh.2019.0026

View: 9606 Download: 237 Web of Science: 8 Crossref: 8

Original Article

Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients

Waleed Seif Eldin Mohamed Mostafa, Mohammed Hassan Saiem Al-Dahr, Dalia Abdel Hamid Omran, Zeinab Fathy Abdullah, Suzan Hamdy Elmasry, Mohamed Nabil Ibrahim

Clin Mol Hepatol. 2020;26(1):60-69. Published online October 22, 2019

DOI: https://doi.org/10.3350/cmh.2019.0051

View: 6093 Download: 133 Web of Science: 4 Crossref: 4

Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard

Jamak Modaresi Esfeh, Kaveh Hajifathalian, Kianoush Ansari-Gilani

Clin Mol Hepatol. 2020;26(1):54-59. Published online November 15, 2019

DOI: https://doi.org/10.3350/cmh.2019.0039

View: 8222 Download: 188 Web of Science: 43 Crossref: 44

Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line

Ankita Makol, Harpreet Kaur, Sakshi Sharma, Shruthi Kanthaje, Ramanpreet Kaur, Anuradha Chakraborti

Clin Mol Hepatol. 2020;26(1):45-53. Published online September 30, 2019

DOI: https://doi.org/10.3350/cmh.2019.0031

View: 7666 Download: 250 Web of Science: 17 Crossref: 14

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection

Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim

Clin Mol Hepatol. 2020;26(1):33-44. Published online June 27, 2019

DOI: https://doi.org/10.3350/cmh.2018.0073

View: 5864 Download: 185 Web of Science: 18 Crossref: 15

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

04 Days

*Last 12 months

Viewed By 5588	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4802	MAFLD: How is it different from NAFLD?
Viewed By 4538	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3711	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3687	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?